BioSpace News Archive

Nephron Pharmaceuticals Corporation celebrated a successful $350 million capital raise – led by BlackRock Capital Investment Advisors, LLC and PNC Bank, National Association – to support future growth of the pharmaceutical manufacturer.

Wexford Science & Technology, LLC announced that the National Institutes of Health has signed a lease at 850 PBC and will use the space to accommodate the Phoenix Epidemiology & Clinical Research Branch of the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases.

United Urology Group and its Affiliate Practices and Prostate Centers USA® are pleased to announce a groundbreaking initiative in the treatment of Benign Prostatic Hyperplasia.

Up to an hour after their hearts had stopped, some patients revived by cardiopulmonary resuscitation had clear memories afterward of experiencing death, and had brain patterns while unconscious linked to thought and memory.

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, for the purchase and sale of 1,100,000 shares of its common stock at a purchase price of $2.63 per share of common stock.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, announced that on September 5, 2023, Anika granted restricted stock units covering 10,000 shares of common stock to one newly hired non-executive employee.

T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens, announced that it issued inducement awards to four new employees.

Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, reported the grant of an aggregate of 39,000 restricted stock units of Arcutis’ common stock to six newly hired employees.

Scholar Rock announced that the company granted inducement equity awards covering an aggregate of 8,750 shares of its common stock to one newly hired employee, consisting of inducement stock options to purchase an aggregate of 5,000 shares of common stock and inducement restricted stock units, covering an aggregate of 3,750 shares of its common stock.